European Heart Journal· 2014Q1· Review
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
- 593citations
- Q1SCImago
- 2014year
Short summary
Systemic thrombolytic therapy significantly reduces overall mortality (OR 0.59), PE-related mortality (OR 0.29), and PE recurrence (OR 0.50) in acute pulmonary embolism (PE) patients, but increases major bleeding risk (OR 2.91).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine